share_log

BMO Capital Maintains Outperform on Aptinyx, Lowers Price Target to $2

Benzinga Real-time News ·  Aug 15, 2022 09:16

BMO Capital analyst Gary Nachman maintains Aptinyx (NASDAQ:APTX) with a Outperform and lowers the price target from $6 to $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment